Seeking Alpha

Amarin (AMRN +1.85%) says the Patent Office has published a notification of a Notice of...

Amarin (AMRN +1.85%) says the Patent Office has published a notification of a Notice of Allowance for an application to widen the company's patent claims to include the use of its heart pill Vascepa with and without other lipid lowering agents, such as statins. A Notice of Allowance means the USPTO has decided that a patent can be granted from an application.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)